WRHAM
TEVA icon

W.R. Huff Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

W.R. Huff Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$2.09M Buy
57,697
+33,082
+134% +$1.32M 1.81% 18
2016
Q3 		$1.13M Buy
+24,615
New +$1.28M 0.9% 33

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

W.R. Huff Asset Management's TEVA Position: Q4 2016 in Review

W.R. Huff Asset Management increased its Teva Pharmaceuticals (TEVA) stake by 134% in Q4 2016, buying an estimated $1.32M and bringing the position to 57,697 shares worth $2.09M. The position accounts for 1.81% of the portfolio, ranked #18.

W.R. Huff Asset Management first reported a position in TEVA in Q3 2016 and has held it in 2 quarters since. 737 funds tracked by Wall St. Rank hold TEVA as of Q4 2016.

  • W.R. Huff Asset Management held 57,697 shares of Teva Pharmaceuticals worth $2.09M as of Q4 2016.
  • W.R. Huff Asset Management bought 33,082 Teva Pharmaceuticals shares in Q4 2016, an estimated $1.32M.
  • Teva Pharmaceuticals made up 1.81% of W.R. Huff Asset Management's portfolio in Q4 2016, its #18 holding.
  • W.R. Huff Asset Management first reported a position in Teva Pharmaceuticals in Q3 2016 and has held it in 2 quarters since.
  • 737 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2016.

Based on W.R. Huff Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.